OP

Opus Point Partners Management, LLC

Sector-focusedMomentum followerQuality / disciplined sizing

Total reported value

$55.3M

Reporting period: 2019-09-30 · Number of holdings: 55

Opus Point Partners Management, LLC disclosed 55 holdings in its latest 13F filing for the period ending 2019-09-30, with total reported value of $55.3M and a quarterly turnover rate of 27.3%.

Personality snowflake

Concentration
62.04
Portfolio Stability
27.27
Momentum/Contrarian
100
Sector conviction
100
Diversification
100
Sizing Uniformity
72.59

Recent moves

  • Add IBB

    0.0%　-$2.0M

  • Trim LABUUSD

    +1.4%　-$1.9M

  • Add 34960Q109

    +162.2%　$514.0K

  • Add SGENEUR

    +0.7%　$300.0K

  • Add BMY

    0.0%　$176.0K

  • Trim QURE

    0.0%　-$551.0K

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

Showing top 54 holdings (of 55 total)

#TickerIssuerAsset SubclassWeightWeight ChangeShares Change4Q Trend
1IBBIshares Biotechnology ETFETF-Tech37.76%+3.86%—
2LABUUSDDrx Dly S&p Biotech Bull 3xETF-Tech5.58%-1.73%+1.45%
3MTDMettler-toledo InternationalStock-Healthcare4.12%+0.10%—
4BMYBristol-myers Squibb CoStock-Healthcare3.02%+0.81%—
5SGENEURSeagen INCStock-Other2.78%+0.95%+0.66%
6ILMNIllumina INCStock-Healthcare2.59%+0.04%+0.47%
7VRTXVertex Pharmaceuticals INCStock-Healthcare2.54%+0.32%+1.05%
8IONSIonis Pharmaceuticals INCStock-Healthcare2.18%+0.27%—
9ALNYAlnylam Pharmaceuticals INCStock-Healthcare1.99%+0.56%+2.49%
10ALXNAlexion Pharmaceuticals INCStock-Other1.76%-0.16%+0.06%
11QGENQiagen N.V.Stock-Healthcare1.72%-0.01%—
12ONCEEURSpark Therapeutics INCStock-Other1.70%+0.23%—
13✓ Stock-Other1.56%+1.04%+162.17%
14✓ Proqr Thrapeutics N VStock-Other1.44%-0.42%—
15INCYIncyte CORPStock-Healthcare1.43%+0.10%+0.43%
16EXKExact Sciences CORPStock-Materials1.39%-0.10%—
17REGNRegeneron PharmaceuticalsStock-Healthcare1.22%—+9.82%
18BMRNBiomarin Pharmaceutical INCStock-Healthcare1.18%-0.01%+3.19%
19DCPHEURDeciphera Pharmaceuticals InStock-Other1.14%+0.52%—
20ASNDAscendis Pharma A/SStock-Other1.08%+0.03%—
21QUREuniQure N.V.Stock-Other1.01%-0.63%—
22CELGCelgene CORPStock-Other1.01%+0.24%—
23CRSPCRISPR Therapeutics AGStock-Healthcare0.98%+0.06%—
24EPZMEUREpizyme INCStock-Other0.94%——
25✓ Amarin Corp PLCStock-Other0.92%+0.44%+102.16%
262655787DBlueprint Medicines CORPStock-Other0.90%-0.05%—
27BOLDEURAudentes Therapeutics INCStock-Other0.88%-0.09%—
28GTHXEURG1 Therapeutics INCStock-Other0.86%-0.09%—
29GBTUSDGlobal Blood Therapeutics InStock-Other0.83%+0.09%—
30BHVNBiohaven Ltd.Stock-Other0.82%——
31ARNAEURArena Pharmaceuticals INCStock-Other0.81%-0.04%—
32ACADAcadia Pharmaceuticals INCStock-Healthcare0.78%+0.31%+0.20%
33GWPHGw Pharmaceuticals LTDStock-Other0.76%-0.18%—
34ZGNXEURZogenix INCStock-Other0.70%+0.01%—
35MGNXMacrogenics INCStock-Other0.69%-0.06%—
36NTLAIntellia Therapeutics INCStock-Other0.69%——
37TECHBio-techne CORPStock-Healthcare0.55%——
38IQVIqvia Holdings INCStock-Healthcare0.54%——
39AMGNAmgen INCStock-Healthcare0.53%—+8.66%
40NBIXNeurocrine Biosciences INCStock-Healthcare0.51%—+3.82%
41CKPTUSDCheckpoint Therapeutics INCStock-Other0.51%——
42CRLCharles River LaboratoriesStock-Healthcare0.51%——
43UTHRUnited Therapeutics CORPStock-Healthcare0.50%+0.50%NEW
44GRFSGrifols Sa-adrStock-Other0.48%——
45BIIBBiogen INCStock-Healthcare0.47%——
46ICPTUSDIntercept Pharmaceuticals InStock-Other0.47%-0.22%-33.14%
47GILDGilead Sciences INCStock-Healthcare0.47%——
48LGNDLigand PharmaceuticalsStock-Healthcare0.44%—+15.02%
49NKTREURNektar TherapeuticsStock-Other0.42%-0.24%+3.39%
50EXELExelixis INCStock-Healthcare0.42%—+14.79%
1–50 of 54

Holding changes this quarter

Opus Point Partners Management, LLC's most significant position changes for 2019-09-30: Sold out: Immunomedics INC (IMMU); Sold out: Sarepta Therapeutics INC (SRPT); Sold out: ; Sold out: Insmed INC (INSM); Sold out: Pacira Biosciences INC (PCRX).

Position changes disclosed by Opus Point Partners Management, LLC for the quarter ending 2019-09-30, including ticker, issuer, weight change, shares change, and action
#TickerIssuerWeight ChangeShares ChangeAction
1IBBIshares Biotechnology ETF+3.9%—Unchanged
2✓ +1%+162.17%Add
3SGENEURSeagen INC+1%+0.66%Add
4BMYBristol-myers Squibb Co+0.8%—Unchanged
5ALNYAlnylam Pharmaceuticals INC+0.6%+2.49%Add
6DCPHEURDeciphera Pharmaceuticals In+0.5%—Unchanged
7✓ Amarin Corp PLC+0.4%+102.16%Add
8VRTXVertex Pharmaceuticals INC+0.3%+1.05%Add
9ACADAcadia Pharmaceuticals INC+0.3%+0.20%Add
10IONSIonis Pharmaceuticals INC+0.3%—Unchanged
11CELGCelgene CORP+0.2%—Unchanged
12ONCEEURSpark Therapeutics INC+0.2%—Unchanged
13MTDMettler-toledo International+0.1%—Unchanged
14INCYIncyte CORP+0.1%+0.43%Add
15GBTUSDGlobal Blood Therapeutics In+0.1%—Unchanged
16CRSPCRISPR Therapeutics AG+0.1%—Unchanged
17ILMNIllumina INC0%+0.47%Add
18ASNDAscendis Pharma A/S0%—Unchanged
19ZGNXEURZogenix INC0%—Unchanged
20EPZMEUREpizyme INC——Unchanged
21NTLAIntellia Therapeutics INC——Unchanged
22CKPTUSDCheckpoint Therapeutics INC——Unchanged
23QGENQiagen N.V.0%—Unchanged
24BMRNBiomarin Pharmaceutical INC0%+3.19%Add
25ARNAEURArena Pharmaceuticals INC0%—Unchanged
262655787DBlueprint Medicines CORP-0.1%—Unchanged
27MGNXMacrogenics INC-0.1%—Unchanged
28BOLDEURAudentes Therapeutics INC-0.1%—Unchanged
29GTHXEURG1 Therapeutics INC-0.1%—Unchanged
30RAREUltragenyx Pharmaceutical In-0.1%—Unchanged
31EXKExact Sciences CORP-0.1%—Unchanged
32ALXNAlexion Pharmaceuticals INC-0.2%+0.06%Add
33GWPHGw Pharmaceuticals LTD-0.2%—Unchanged
34ICPTUSDIntercept Pharmaceuticals In-0.2%-33.14%Trim
35NKTREURNektar Therapeutics-0.2%+3.39%Add
36✓ Proqr Thrapeutics N V-0.4%—Unchanged
37QUREuniQure N.V.-0.6%—Unchanged
38LABUUSDDrx Dly S&p Biotech Bull 3x-1.7%+1.45%Add
39IMMUImmunomedics INC—EXITSold out
40SRPTSarepta Therapeutics INC—EXITSold out
41✓ —EXITSold out
42INSMInsmed INC—EXITSold out
43PCRXPacira Biosciences INC—EXITSold out
44AM6Amicus Therapeutics INC—EXITSold out
45VKTXViking Therapeutics INC—EXITSold out
46MDGLMadrigal Pharmaceuticals INC—EXITSold out
47ANABAnaptysbio INC—EXITSold out
48UTHRUnited Therapeutics CORP—NEWNew buy
49AGIOAgios Pharmaceuticals INC—EXITSold out
50ALKSAlkermes plc—NEWNew buy

FAQ

What is Opus Point Partners Management, LLC and what type of investor is it?
Opus Point Partners Management, LLC is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2019-09-30), the firm manages a tracked equity portfolio valued at approximately $55.3M, spread across 55 disclosed positions.
What are Opus Point Partners Management, LLC's largest equity positions?
Based on the latest 13F filing, Opus Point Partners Management, LLC's top holdings by market value are: 1. Ishares Biotechnology ETF (IBB) — $20.9M (37.8%) 2. Drx Dly S&p Biotech Bull 3x (LABUUSD) — $3.1M (5.6%) 3. Mettler-toledo International (MTD) — $2.3M (4.1%) 4. Bristol-myers Squibb Co (BMY) — $1.7M (3.0%) 5. Seagen INC (SGENEUR) — $1.5M (2.8%)
What changes did Opus Point Partners Management, LLC make in its most recent portfolio filing?
In the latest reported quarter, Opus Point Partners Management, LLC made 25 notable position adjustments: 2 new positions were initiated, 12 existing holdings were added to, 1 positions were partially reduced, and 10 were completely exited. The largest of these moves: Sold out: Immunomedics INC (IMMU); Sold out: Sarepta Therapeutics INC (SRPT); Sold out: ; Sold out: Insmed INC (INSM); Sold out: Pacira Biosciences INC (PCRX)
What sectors does Opus Point Partners Management, LLC focus on?
Opus Point Partners Management, LLC is concentrated in the following sectors based on its current disclosed equity portfolio: • Health Care: 100.0%